Koen Stas

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat, Youssef M.K. Farag et autres

BACKGROUND: In patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), finerenone, a nonsteroidal mineralocorticoid receptor antagonist, reduces cardiovascular and kidney failure outcomes. Finerenone also lowers the urine albumin-to-creatinine ratio (UACR). Whether finerenone-induced change in UACR mediates cardiovascular and kidney …

us, gb, de, es, dk, gr, pl (code pays fourni par la source)

Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897

Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et autres

In Fig. 2 of the article cited above, due to a typographical error, the hazard ratio (HR) of the key secondary composite kidney outcome in the insulin at baseline subgroup was incorrectly reported as 0.74 (95% CI 0.59–0.94) instead of the correct …

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt et autres

OBJECTIVE: Finerenone reduced the risk of kidney and cardiovascular events in people with chronic kidney disease (CKD) and type 2 diabetes in the FIDELIO-DKD and FIGARO-DKD phase 3 studies. Effects of finerenone on outcomes in patients taking sodium-glucose cotransporter 2 inhibitors (SGLT2is) …

dk, de, gr, us, es, gb (code pays fourni par la source)

Heterologous versus homologous triple anti-COVID-19 vaccine regimens in patients on maintenance haemodialysis

Björn Meijers, Annelien Goedgezelschap, Domien Peeters, Annelien van der Veen et autres

We thank all patients for their participation in this study and for providing informed consent. We thank the nursing staff for their dedication to safeguarding the patients as best they can. B.M. is supported by the research foundation Flanders (Senior clinical investigator …

be (code pays fourni par la source)

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos et autres

OBJECTIVE: Finerenone significantly improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease trial. We explored whether baseline HbA1c level and insulin treatment …

dk, ca, us, de, gr, es, be, au, il (code pays fourni par la source)

Renale relaxatie ter preventie van renale burn-out: een praktische gids

Bart De Moor, Koen Stas

Dit verhalend overzicht schetst het concept van renale relaxatie op basis van de meeste recente inzichten, onderbouwd door adviezen uit bestaande richtlijnen voor chronisch nierlijden. Een gemeten of geschatte glomerulaire filtratiesnelheid (glomerular filtration rate of GFR) weerspiegelt de som van de activiteit …

Haemodynamic or metabolic stimulation tests to reveal the renal functional response: requiem or revival?

Bart De Moor, Johan Vanwalleghem, Q. Swennen, Koen Stas et autres

Renal stimulation tests document the dynamic response of the glomerular filtration rate (GFR) after a single or a combination of stimuli, such as an intravenous infusion of dopamine or amino acids or an oral protein meal. The increment of the GFR above …

be (code pays fourni par la source)

Coxsackievirus B1 peritonitis in a patient treated with continuous ambulatory peritoneal dialysis: a case report and brief review of the literature

Steven Pauwels, Bart De Moor, Koen Stas, Koen Magerman et autres

be, nl (code pays fourni par la source)

Coxsackievirus B1 peritonitis in a Patient Treated with Continuous Ambulatory Peritoneal Dialysis. A Case Report and Brief Review of the Literature.

Steven Pauwels, Bart De Moor, Koen Stas, Koen Magerman et autres

be, nl (code pays fourni par la source)

Acute kidney injury after use of oral Fleet Phospho Soda as bowel preparation for colonoscopy.

William Jacobs, Koen Stas, J-L Coenegrachts

We present a case of a 64-year old woman who developed acute kidney injury (AKI) finally resulting in stage 4 chronic kidney disease after ingestion of a high phosphate containing solution (oral Fleet Phospho Soda) as bowel cleansing for colonoscopy.

be (code pays fourni par la source)

Alcohol en de nier. Schadelijke en protectieve effecten

T CORNELIS, H KEULEERS, Bart De Moor, J VANWALLEGHEM et autres

Auteur(s): CORNELIS T, KEULEERS H, DE MOOR B, VANWALLEGHEM J, STAS K , | Samenvatting: Alcoholmisbruik komt vaak voor in onze samenleving en leidt tot aanzienlijke morbiditeit en mortaliteit.Alcohol heeft welgekende nefaste effecten op de lever, de pancreas, de hersenen en het …

Substantial reduction of infectious complications in hemodialysis patients with trisodium citrate 30% as catheter locking solution; a prospective multicenter double-blind randomised controlled trial

Marcel C. Weijmer, Marinus A. van den Dorpel, J.A.C.A. van Geelen, Han O. Groeneveld et autres